Showing results (2141-2150 of 2,190) with videos related to

Sort By:
Pageof 219
Nature Medicine|August 15, 2023
Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial resultsAlexander M Lesokhin, Michael H Tomasson, Bertrand Arnulf, et al.
Cell Host & Microbe|September 17, 2020
Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2Sandra C A Nielsen, Fan Yang, Katherine J L Jackson, et al.
American Journal of Human Genetics|June 25, 2011
Using VAAST to identify an X-linked disorder resulting in lethality in male infants due to N-terminal acetyltransferase deficiencyAlan F Rope, Kai Wang, Rune Evjenth, et al.
The New England Journal of Medicine|December 8, 2015
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic LeukemiaJan A Burger, Alessandra Tedeschi, Paul M Barr, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2020
SARS-CoV-2 Antibody Responses Correlate with Resolution of RNAemia But Are Short-Lived in Patients with Mild IllnessKatharina Röltgen, Oliver F Wirz, Bryan A Stevens, et al.
Lancet (London, England)|January 19, 2016
Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trialSagar Lonial, Brendan M Weiss, Saad Z Usmani, et al.
Science Immunology|December 8, 2020
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcomeKatharina Röltgen, Abigail E Powell, Oliver F Wirz, et al.
Ecology and Evolution|January 19, 2026
The Secret Life of Tidal Marshes and Mangroves: Camera Trapping as a Window Into Wildlife Using North American Coastal WetlandsKenneth B Raposa, Kimberly Cressman, Danika vanProosdij, et al.
Pageof 219